Aisling Capital

Biotechnology · Venture Capital
118investments
35exits
$350Mraised by its portfolio in 12 months
3,577open roles in its portfolio

Overview

Aisling Capital is a private investment firm focused on the healthcare and life sciences sector. It invests in biotechnology, specialty pharmaceutical, medical device and healthcare companies, providing growth capital to both private and publicly traded businesses. The firm traces its roots to 2000, when its team began managing a biopharmaceutical fund originally linked to Perseus and Soros, and it is based in New York City.

Investor profile

Venture capital
Investments
118
22 of them startups
Hiring now
27
3,577 open roles
Rounds in 12 months
4
$350M raised
Exits
35
Focusshare of its companies
Health Care 80%Biotechnology 25%Consumer Goods 8%Food & Beverages 8%Consumer Electronics 6%Farming & Agriculture 4%Sports 4%Travel & Tourism 4%
Where its companies are
United States 29%United Kingdom 3%Canada 2%Denmark 1%Switzerland 1%
Stage of its companies
Series C and later 38%Series B 28%Series A 22%Pre-seed & seed 13%
Its companies, the freshest money firstAll 118 investments
Dren BioVenture round $350M · this month GSK plcVenture round · 1 mo ago Compass PathwaysVenture round · 1 mo ago · 67 roles F2G.Venture round · 11 mo ago WugenVenture round $123.3M · 14 mo ago Treeline BiosciencesVenture round $200.1M · 14 mo ago · 8 roles EarlensVenture round $8M · 20 mo ago avrobio.comVenture round $185M · 21 mo ago Marker TherapeuticsVenture round $16.1M · 22 mo ago CalciMedicaVenture round $10.3M · 3 yr ago Antios TherapeuticsSeries B $75M · 5 yr ago Merck.comVenture round $486 · 5 yr ago · 3 roles
3,577 open roles at 27 of its companies
Hiring fastestroles opened in 30 days
Johnson & Johnson845 new roles in 30 days Merck & Co.445 new roles in 30 days Pfizer248 new roles in 30 days Reckitt222 new roles in 30 days Galderma162 new roles in 30 days Gilead Sciences119 new roles in 30 days
Co-investorscompanies they hold together
NEA 13 shared RA Capital Management 12 shared Omega Funds 11 shared EcoR1 Capital 8 shared Foresite Capital 8 shared Sofinnova Investments 7 shared Longitude Capital 5 shared Sofinnova Partners 4 shared ARCH Venture Partners 4 shared GV 4 shared
Similar investorstheir companies share markets and countries
RA Capital Management Omega Funds venBio Partners Sofinnova Investments Foresite Capital Atlas Venture Longitude Capital EcoR1 Capital
Sources: its portfolio page, read Nov 8

Offices

Where the company hires and what each office is for
Cities
1
Hiring now
0
Countries
1
New York United States
HQ
489 5th Avenue 10th Floor New York, NY 10017
200-500 est. staff
489 5th Avenue, 10th Floor, New York, 10017
company site